JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120056

Staurosporine, Protein kinase inhibitor

Be the first to review this product! Submit a review

|

(34 Publications)

Potent, cell-permeable, broad spectrum inhibitor of protein kinases. Kinases inhibited include: protein kinase C (PKC) (IC50 = 3 nM), cAMP-dependent protein kinase (IC50 = 8 nM) and p60v-src (IC50 = 6 nM). MW 466.5

- Competitive inhibition at the ATP binding site
6 Images
Chemical Structure - Staurosporine, Protein kinase inhibitor (AB120056)
  • Chemical Structure

Lab

Chemical Structure - Staurosporine, Protein kinase inhibitor (AB120056)

2D chemical structure image of ab120056, Staurosporine, Protein kinase inhibitor

Functional Studies - Staurosporine, Protein kinase inhibitor (AB120056)
  • FuncS

Unknown

Functional Studies - Staurosporine, Protein kinase inhibitor (AB120056)

Example of IC50 determination. HeLa cells were treated with a dose titration of Staurosporine for 4 hours in complete media. Cells were cultured and treated in a 96-well cell culture microtiter plate. Lysates were prepared by direct in-well lysis without media removal : 2X Cell Extraction Buffer PTR was added to an equal volume of media and then resulting lysate was used directly in the Cleaved PARP SimpleStepTM ELISA assay. Raw values for triplicate measurements are plotted. The calculated IC50 is 0.77 μM.

Functional Studies - Staurosporine, Protein kinase inhibitor (AB120056)
  • FuncS

Unknown

Functional Studies - Staurosporine, Protein kinase inhibitor (AB120056)

Example of HeLa staurosporine (ab120056) treated cell lysate titration. Background-subtracted data values (mean +/- SD) are graphed.

Functional Studies - Staurosporine, Protein kinase inhibitor (AB120056)
  • FuncS

Unknown

Functional Studies - Staurosporine, Protein kinase inhibitor (AB120056)

HeLa and Jurkat cells were treated with 1 µM Staurosporine (STS) (ab120056) for 4 hours in complete cell culture media to induce apoptosis and cleaved PARP protein. Untreated and STS treated HeLa and Jurkat lysates were prepared in 1X Cell Extraction Buffer PTR and tested the Cleaved PARP SimpleStepTM ELISA. Raw OD 450 nm values are shown for 500 µg/mL lysate loads.

Functional Studies - Staurosporine, Protein kinase inhibitor (AB120056)
  • FuncS

Unknown

Functional Studies - Staurosporine, Protein kinase inhibitor (AB120056)

Demonstration of Cleaved PARP capture antibody specificity by western blot assay. 20 μg of HeLa extracts that were untreated or treated for 4 hours with 1 μM Staurosporine were analyzed by western blot. The GAPDH blot is included to show the relative loads of each lysate. In the HeLa cell line, Staurosporine treatment is required to detect cleaved PARP protein, as observed in the SimpleStep ELISA.

Functional Studies - Staurosporine, Protein kinase inhibitor (AB120056)
  • FuncS

Unknown

Functional Studies - Staurosporine, Protein kinase inhibitor (AB120056)

Lane 1 : HeLa, vehicle (DMSO) treated for 4 hours Lane 2 : HeLa 1 μM staurpsorine (ab120056), 4 hours Load 20 μg/lane 5% milk/PBST for block and antibody diluent Primary antibodies (2 hours, room temp) All lanes : ab136812 250X Primary Antibodies Cocktail, 1/250 dilution Secondary antibodies (1 hour, room temp) All lanes : ab136812 100X HRP-Conjugated Secondary Antibodies Cocktail, 1/100 dilution

Key facts

CAS number

62996-74-1

Purity

>98%

Form

Solid

form

Molecular weight

466.5 Da

Molecular formula

C<sub>2</sub><sub>8</sub>H<sub>2</sub><sub>6</sub>N<sub>4</sub>O<sub>3</sub>

PubChem

44259

Nature

Synthetic

Solubility

Soluble in DMSO to 50 mM

Biochemical name

Staurosporine

Biological description

Potent, cell-permeable, broad spectrum inhibitor of protein kinases. Kinases inhibited include: protein kinase C (IC50 = 3 nM), cAMP-dependent protein kinase (IC50 = 8 nM) and p60v-src (IC50 = 6 nM).

Canonical smiles

CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)NC)OC

Isomeric smiles

C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)NC)OC

InChi

InChI=1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1

InChiKey

HKSZLNNOFSGOKW-FYTWVXJKSA-N

IUPAC Name

(2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one

Product details

Check out our range of Protein kinase inhibitor biochemicals here

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PKC isoforms associate with cancer and cardiovascular diseases. PKC epsilon often links with cancer progression particularly breast and lung cancers by interacting with oncogenes that promote tumor growth. PKC beta 2 shows connections with metabolic disorders especially in the context of cardiac dysfunction. Disease links may involve other proteins such as Src kinase which interacts with PKC pathways affecting cell motility and survival in cancerous conditions. Understanding these relationships aids in developing therapeutic strategies targeting PKC-related pathways in disease treatment.
Pathways

Several PKC isoforms engage critical cell signaling pathways such as the MAPK/ERK pathway and the PI3K/AKT pathway. In these pathways PKCs modulate various downstream effectors coordinating signals that influence gene expression and cell survival. PKC delta has significant associations with the MAPK cascade while PKC theta interacts closely with PI3K. These interactions are necessary for linking external signals to intracellular responses thereby acting as converging points for signaling pathways impacting multiple cellular functions.

Biological function summary

PKC isoforms regulate cellular functions like proliferation differentiation and apoptosis. These proteins are part of larger signaling complexes participating in dynamic equilibrium states that determine cellular fate. For example PKC epsilon often interacts within complexes modulating oncogenic pathways while PKC beta 2 plays roles in immune response modulation. The distinct expression patterns and interactions of these isoforms enable them to assume specific biological roles in different tissues.

Protein kinase C (PKC) is a family of serine/threonine kinases essential in cellular signaling. The PKC family includes several isoforms such as PKC delta PKC epsilon PKC beta 2 PKC gamma and PKC theta (also known as PRKCQ). These proteins exhibit diverse molecular masses ranging from about 78 kDa to 82 kDa. PKCs are broadly expressed in various tissues and cells particularly in the brain heart and immune cells. PKC isoforms play significant mechanical roles by phosphorylating various substrate proteins influencing various cellular processes.

Product protocols

Publications (34)

Recent publications for all applications. Explore the full list and refine your search

Journal of translational medicine 22:868 PubMed39334383

2024

Survival advantage of native and engineered T cells is acquired by mitochondrial transfer from mesenchymal stem cells.

Applications

Unspecified application

Species

Unspecified reactive species

Angela C Court,Eliseo Parra-Crisóstomo,Pablo Castro-Córdova,Luiza Abdo,Emmanuel Arthur Albuquerque Aragão,Rocío Lorca,Fernando E Figueroa,Martín Hernán Bonamino,Maroun Khoury

The EMBO journal 43:5237-5259 PubMed39271794

2024

Requirement of Nek2a and cyclin A2 for Wapl-dependent removal of cohesin from prophase chromatin.

Applications

Unspecified application

Species

Unspecified reactive species

Susanne Hellmuth,Olaf Stemmann

Neurobiology of stress 28:100593 PubMed38075025

2023

Glucocorticoids modulate neural activity via a rapid non-genomic effect on Kv2.2 channels in the central nervous system.

Applications

Unspecified application

Species

Unspecified reactive species

Yuqi Wang,Yuchen Zhang,Jiawei Hu,Chengfang Pan,Yiming Gao,Qingzhuo Liu,Wendong Xu,Lei Xue,Changlong Hu

iScience 26:108080 PubMed37860693

2023

The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity.

Applications

Unspecified application

Species

Unspecified reactive species

Hazel Stewart,Yongxu Lu,Sarah O'Keefe,Anusha Valpadashi,Luis Daniel Cruz-Zaragoza,Hendrik A Michel,Samantha K Nguyen,George W Carnell,Nina Lukhovitskaya,Rachel Milligan,Yasmin Adewusi,Irwin Jungreis,Valeria Lulla,David A Matthews,Stephen High,Peter Rehling,Edward Emmott,Jonathan L Heeney,Andrew D Davidson,James R Edgar,Geoffrey L Smith,Andrew E Firth

iScience 26:107323 PubMed37529105

2023

Ebola virus shed glycoprotein is toxic to human T, B, and natural killer lymphocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Luis J Perez-Valencia,Kevin M Vannella,Marcos J Ramos-Benitez,Junfeng Sun,Mones Abu-Asab,David W Dorward,Keytam S Awad,Andrew Platt,Eliana Jacobson,Jason Kindrachuk,Daniel S Chertow

Brain : a journal of neurology 146:4378-4394 PubMed37070763

2023

Glucocorticoid-driven mitochondrial damage stimulates Tau pathology.

Applications

Unspecified application

Species

Unspecified reactive species

Fang Du,Qing Yu,Russell H Swerdlow,Clarissa L Waites

Rheumatology (Oxford, England) 62:3197-3204 PubMed36708011

2023

Reduced digestion of circulating genomic DNA in systemic sclerosis patients with the DNASE1L3 R206C variant.

Applications

Unspecified application

Species

Unspecified reactive species

Brian Skaug,Xinjian Guo,Yuanteng Jeff Li,Julio Charles,Kay T Pham,Jacob Couturier,Dorothy E Lewis,Claudia Bracaglia,Ivan Caiello,Maureen D Mayes,Shervin Assassi

Cancers 13: PubMed34572749

2021

Protein Ligands in the Secretome of CD36 Fibroblasts Induce Growth Suppression in a Subset of Breast Cancer Cell Lines.

Applications

Unspecified application

Species

Unspecified reactive species

Kosar Jabbari,Garrett Winkelmaier,Cody Andersen,Paul Yaswen,David Quilici,Saori Furuta,Qingsu Cheng,Bahram Parvin

PLoS pathogens 17:e1009458 PubMed34383863

2021

Measles virus exits human airway epithelia within dislodged metabolically active infectious centers.

Applications

Unspecified application

Species

Unspecified reactive species

Camilla E Hippee,Brajesh K Singh,Andrew L Thurman,Ashley L Cooney,Alejandro A Pezzulo,Roberto Cattaneo,Patrick L Sinn

Nature 596:262-267 PubMed34349263

2021

Microbes exploit death-induced nutrient release by gut epithelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Christopher J Anderson,Christopher B Medina,Brady J Barron,Laura Karvelyte,Tania Løve Aaes,Irina Lambertz,Justin S A Perry,Parul Mehrotra,Amanda Gonçalves,Kelly Lemeire,Gillian Blancke,Vanessa Andries,Farzaneh Ghazavi,Arne Martens,Geert van Loo,Lars Vereecke,Peter Vandenabeele,Kodi S Ravichandran
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com